Death receptors have been recently identified as a subgroup of the TNF-receptor superfamily with a predominant function in induction of apoptosis. The receptors are characterized by an intracellular region, called the death domain, which is required for the transmission of the cytotoxic signal. Currently, five different such death receptors are known including tumor necrosis factor (TNF) receptor-1, CD95 (Fas/ APO-1), TNF-receptor-related apoptosis-mediated protein (TRAMP) and TNF-related apoptosis-inducing ligand (TRAIL) receptor-1 and -2. The signaling pathways by which these receptors induce apoptosis are rather similar. Ligand binding induces receptor oligomerization, followed by the recruitment of an adaptor protein to the death domain through homophilic interaction. The adaptor protein then binds a proximal caspase, thereby connecting receptor signaling to the apoptotic effector machinery. In addition, further pathways have been linked to death receptor-mediated apoptosis, such as sphingomyelinases, JNK kinases and oxidative stress. These pro-apoptotic signals are counteracted by several mechanisms which inhibit apoptosis at different levels. This review summarizes the current and rapidly expanding knowledge about the biological functions of death receptors and the mechanisms to trigger or to counteract cell death.
photoxin-A (LTA, TNFβ) and TRAIL bind to death receptors [23, 24] . It was not surprising to find that, in addition to the receptors, also the ligands display structural similarities, which are reflected by similar mechanisms of receptor recognition and triggering. The ligands recognize their receptors through a shared structure composed of anti-parallel β-sheets arranged in a jelly roll structure. As supported by structural and biochemical data, it is believed that all active ligands consist of three identical subunits and activate their receptors by oligomerization [25Ϫ 28] . Another common feature of the ligands is that almost all of them are type II transmembrane proteins. The only exception is LTA which, although formed as a soluble protein, binds to membrane-bound LTβ and thereby also acts as a cell-bound form. Lymphotoxins can be found as homotrimers (LTA 3 ) or heterotrimers (LTA 1 /β 2 or LTA 2 /β 1 ). The LTA homotrimer binds the TNF receptors, whereas the heterotrimers bind to the LTβ recep- dependent metalloprotease, called TACE (TNFA-converting enzyme) was recently cloned and shown to specifically cleave TNF [29, 30] . been reported. However, most of them also have other functions such as induction of proliferation, differentiation, immune regu-Biological functions of death receptors lation and gene expression. Receptors with pleiotropic functions include TNF-R1, TNF-R2, NGF-R, CD27, CD30, CD40, OX-TNF was isolated more than 15 years ago, based on its ability to kill tumor cells in vitro and to cause hemorrhagic necrosis 40, NGF-R, TRAMP (DR3/wsl-1/APO-3/LARD), HVEM (ATAR/TR2), GITR and RANK (for references see [1Ϫ3] ). of a transplantable tumor (MethA sarcoma) in mice. Because TNF proved to be highly toxic in animals and humans, it did These receptors are type I membrane proteins which are structurally similar. Each possesses in its extracellular domain twoϪ not fulfill initial expectations in the treatment of cancer. Considerable evidence suggests that inappropriate expression of six imperfect repeats of about 40 amino acids, with each of approximately six Cys residues. Their cytoplasmic domains gen-TNF plays a crucial role in various acute and chronic inflammatory disorders (reviewed in [31Ϫ34]). The CD95 (APO-1, Fas) erally lack considerable sequence similarity.
APO-1/Fas, now called CD95, was the first member of the molecule has been identified much later as a cell surface receptor that could mediate apoptotic cell death of transformed cells TNF receptor superfamily described in terms of its function in apoptosis [4, 5] . Sequence comparison of the intracellular do- [35, 36] . Agonistic antibodies that were specific to human CD95 were able to cause regression of experimental human tumors main of CD95 with TNF-R1 revealed that both receptors contained a similar stretch of about 80 amino acids. This region has growing in nude mice [35] . Although due to the high systemic side effects, application of CD95-mediated apoptosis has also been designated the death domain (DD) since it enables transmission of a cytotoxic signal by both molecules [6, 7] . Recent not held its promise as a potential cancer therapy, some evidence has now documented a pivotal role of CD95 in various physiosimilarity searches in EST databases led to the cloning of a number of novel membrane receptors that contain such a death logical and pathological forms of cell death [37Ϫ39] . Finally, TRAIL and its different receptors have been identified as a novel domain and are therefore referred to as the death receptors (DRs) (Fig. 1) . TRAMP (DR3/wsl-1/APO-3/LARD), is both structur-complex receptor/ligand system. TRAIL is able to induce apoptosis in many transformed cells. In contrast to TNF and ally and functionally similar to TNF-R1 and is abundantly expressed in T-lymphocytes [2, 8Ϫ11]. TRAIL-R1 (DR4, APO-2) CD95L, no side effects of TRAIL on normal primary cells have yet been reported. Thus, whether the TRAIL pathway represents and TRAIL-R2 (DR5) have been found as receptors binding to a novel cytokine, called TRAIL for TNF-related apoptosis-in-the long-sought-after means to selectively kill tumor cells remains to be shown. In the following, we will describe the releducing ligand. The two TRAIL receptors are functionally similar to CD95 as their main function seems to be to induce apoptosis vance and some biological functions of these receptors within the organism. Although most functions have been described in [12Ϫ18] . The TRAIL system, in addition, consists of two neutralizing decoy receptors, called DcR1 (TRAIL-R3, TRID, LIT) the immune system, death receptors are involved in a number of very different apoptotic settings ranging from cell homeostasis, and DcR2 (TRAIL-R4) [13Ϫ16, 19Ϫ22] . The sequence of DcR1 encodes a protein that contains the external TRAIL-bind-organ development, immune privilege and anticancer treatment. ing region as well as a stretch of amino acids that anchors the receptor to the membrane. But, unlike the other receptors, DcR1
The CD95 system. Our understanding of the function of the CD95 receptor and its ligand has been mainly elucidated by the lacks an intracellular tail needed to spark the death pathway. DcR2 is also able to bind TRAIL but contains a truncated death finding that both molecules are mutated in mouse strains suffering from severe autoimmune diseases. lpr (for lymphoproliferadomain. Thus, both decoy receptors will prevent TRAIL from engaging functional TRAIL receptors and thereby render cells tion) mice, which lack a functional CD95 receptor, as well as gld (for generalized lymphoproliferative disease) mice, which resistant to apoptosis. Collectively, this underlines that the death domain is required to induce apoptosis triggered by the different bear a mutant CD95, ligand exhibit various autoimmune phenomena resembling systemic lupus erythematosus in humans surface receptors.
For most members of the TNF-R superfamily their cognate [40, 41] . Both mouse strains produce autoantibodies and accumulate CD4 Ϫ CD8 Ϫ T cells leading to lymphadenopathy, splenoligands have been identified. Four of them, CD95L, TNF, lym-megaly and other signs of autoimmune disorders. The gld defect blasts expressing ectopic CD95L protected allogeneic pancreatic islets co-implanted under the kidney capsule of animals with arises from a point mutation within the CD95L gene, changing an amino acid critical for CD95 binding. The lpr mutation is streptozotocin-induced diabetes [62] . These grafts, which were quickly rejected if myoblasts did not express CD95L, maincaused by the insertion of a transposable element into intron 2 of the CD95 gene, thereby preventing full-length transcription tained their function for an extended period of time. Consistent with this was the observation that allogeneic islets showed de- [42] . Recently, in humans a similar disease with a dysfunction of CD95 was reported [43Ϫ45] . Children with autoimmune lym-layed rejection when co-implanted with CD95L-expressing testis tissue [63] . phoproliferative syndrome (ALPS), also called Canale-Smith syndrome, have massive nonmalignant lymphadenopathy, hepa-CD95L-mediated depletion of cytotoxic T-lymphocytes may not only be beneficial but may also play a role for tumor cells tosplenomegaly, altered T cell populations and other manifestations of systemic autoimmunity. The loss-of-function phenotype to escape the host's immunosurveillance. Recently, high-constitutive CD95L expression has been found in distinct lineages of in mouse and man indicates that CD95 plays an important role in the regulation of the immune response and maintenance of tumors, such as colon, lung, renal carcinoma, melanoma, hepatocellular carcinoma, astrocytoma and T-and B-cell-derived neoself-tolerance.
Molecular studies provided evidence that CD95 is the media-plasms [64Ϫ70]. This suggested that the same mechanisms responsible for protecting tissues from autoimmune destruction tor of activation-induced cell death (AICD), a form of apoptosis important for the downsizing of the immune response, as well may be also used by tumors in eliminating activated lymphocytes that attempt to attack tumor cells. as an effector of cytotoxic T-cell activity [46Ϫ50]. In contrast, there is no convincing evidence that CD95 is involved in negaHowever, there are some conditions where the presence of CD95L may not be involved in immunosuppression but rather tive selection. This assumption is consistent with a relatively normal thymic architecture and proper thymic deletion of acti-associated with inflammatory tissue damage. A role of CD95L-induced apoptosis has been, for instance, implicated in alcoholvated T cells in lpr mice [51, 52] . lpr and gld mice further show B-cell hyperreactivity associated with the production of autoan-induced hepatitis, graft-versus-host disease and autoimmune diseases, such as diabetes and encephalomyelitis [71Ϫ75]. Allison tibodies, suggesting that CD95 also controls the expansion of the B-cell compartment (reviewed in [37, 53] ). et al. [76] reported that transgenic expression of CD95L in pancreatic islets failed to protect these from allogeneic transplant Just as a defect of the CD95 system is intimately linked to autoimmune diseases caused by the impaired removal of autore-rejection when placed under the kidney capsule. The presence of CD95L rather induced a granulocytic infiltrate, which is reactive lymphocytes, so may inappropriate induction of apoptosis lead to pathological conditions. Evidence exists that CD95 is lated to a report showing that CD95L on tumor cells can induce a rejection reaction [77] . In these cases, CD95L expression critically involved in the progression of viral diseases, such as HIV-1 or hepatitis B virus infections where massive apoptosis causes tissue damage directly, or indirectly by recruitment of granulocytes. Indeed, it has been found that CD95 ligation can occurs. It was shown that indirect mechanisms lead to a sensitization of noninfected T-cells towards AICD after HIV-1 infec-result in secretion of the chemokine IL-8 [78] . In conjunction with T-cell receptor activation, CD95 may act as a costimulatory tion [54, 55] . T-lymphocytes from HIV-1-infected patients exhibit an elevated expression of CD95 and sensitivity towards molecule, enhancing gene expression of IL-2 and other cytokines [79] . In addition, some cell types respond to CD95 ligation CD95-mediated apoptosis [56, 57] . Two HIV-1-derived proteins, gp120 and Tat, have been found to activate the expression of via proliferation and not cell death [79Ϫ82]. However, the overall in vitro and in vivo data suggest that CD95 is a receptor CD95L in T-lymphocytes [54] . This process may cause fratricide or suicide death of uninfected T-lymphocytes and result in the which mainly mediates apoptosis. This is reflected by the observation that, in contrast to TNF, CD95 does not induce the activacontinuous depletion of CD4
ϩ T-cells during AIDS disease. Although CD95L was originally found on activated T-lym-tion of proinflammatory transcription factors, including NF-κB, AP-1 or NF-AT [83] . phocytes, various other non-lymphoid cells can express it. A high constitutive expression is detected in Sertoli cells of the A particular function of CD95 was identified in the thyroid gland. Normal thyrocytes constitutively express functional testis and epithelial cells of the anterior eye chamber [58Ϫ60]. This finding led to the proposal that CD95L is responsible for CD95 ligand but do not express the receptor. However, in Hashimoto's thyroiditis patients, thyrocytes do express CD95, and the maintenance of immune privilege, which characterizes the ability of certain organs to suppress graft rejection, even when these cells undergo apoptosis [84] . Hence, in Hashimoto's thyroiditis the normally protective function of CD95L on thyrocytes transplanted in non-matched individuals. After viral inoculation into the anterior eye chamber, infiltrating lymphocytes and gran-leads to the destruction of the thyroid gland.
An exciting finding was further that several unrelated deathulocytes are eliminated probably due to high expression of CD95L [58, 60] . This apoptosis is not observed in eyes of ani-inducing agents and conditions obviously utilize physiological means of induction of apoptosis. Apoptosis mediated by p53 mals with defective CD95L (gld mice), and the resulting inflammation destroys the tissue. Thus, CD95L is necessary for the may involve CD95, as its gene has been found to be a target of this transcription factor [85] . Also overexpression of the c-Myc, maintenance of the privileged status by killing infiltrating lymphocytes of the host.
which induces cell death under growth-limiting conditions, appears to mediate death, at least partially, by a mechanism requirThe function of CD95 in immune privilege has presumably enormous implications for future transplantation strategies ing CD95/CD95L interaction [86] . An apoptosis-inducing effect of c-Myc was not observed in lpr and gld mice. Furthermore, aimed to avoid allograft rejection. It was recently shown that human corneas express functional CD95L [61] , raising the pos-AICD in T-lymphocytes is blocked by c-Myc antisense oligonucleotides [87] . The mechanism by which c-Myc sensitizes cells sibility that this molecule could act to protect cornea grafts. Examination of corneal transplants in mice supported this idea; for CD95-mediated apoptosis remains to be elucidated.
Recent data demonstrate that anticancer-drug-induced cell while approximately 45% of allogeneic cornea transplants survived for an extended period, no graft survival was seen with death may involve the CD95 system. Several different drugs widely used in chemotherapy of cancers induce CD95L exprescorneas expressing defective CD95 receptor or ligand. A protective effect of CD95L was observed after transplantation of allo-sion in leukemic, hepatocellular and neuroblastoma cells [88Ϫ 90] . Because drug-induced cell death could be inhibited by geneic testis under the kidney capsule [59] . Furthermore, myo-CD95L neutralizing reagents, it was proposed that binding of tors, with TNF-R2 preferentially binding mTNF [101] . TNF-R2 appears to play an auxiliary role in cellular responses to sTNF. CD95L to the receptor then triggers the apoptosis cascade in chemosensitive tumor cells. The up-regulation of CD95L may It has been hypothesized that TNF-R2-bound ligand may be passed over to TNF-R1 to enhance TNF-R1 signaling. This litherefore provide a new idea about the mechanism of action of chemotherapy. It should be pointed out, however, that the in-gand passing may be favoured by the distinct kinetics of ligand association and dissociation at the two receptors. TNF binding volvement of CD95 in this scenario is rather controversial, as some investigators found no different susceptibility between to TNF-R2 has a fast off-rate that creates a locally high TNF concentration at the cell surface which, in turn, facilitates bind-CD95-sensitive and resistant tumor cells [91, 92] .
An interesting situation has been found in cell death induced ing to TNF-R1 which has a slow dissociation rate [98] . The prime physiological activator of TNF-R2 seems to be mTNF, by ultraviolet irradiation. Ultraviolet-induced apoptosis is strongly attenuated in CD95-resistant keratinocytes [93, 94] . It since TNF-R2 can be more strongly stimulated by mTNF rather than by sTNF. As mTNF also signals via TNF-R1, the cooperahas been shown that the irradiation directly oligomerizes and thereby activates death receptors, such as CD95 and TNF-R1. tivity of both receptors leads to responses much stronger than those achievable with sTNF alone. Moreover, it was shown that, This is presumably mediated by energy transfer which induces a conformational change of the receptors. This type of apoptosis upon appropriate activation of TNF-R2, a switch of the cellular response pattern to TNF can occur, such that cells resistant to therefore does not require CD95L expression, but directly engages the CD95 signaling pathway. Altogether, these findings sTNF become susceptible upon contact with mTNF [101] .
Gene targeting and transgene approaches have been used to demonstrate that CD95 plays a role in very diverse apoptosis settings.
unravel the in vivo role of the TNF system. TNF (Ϫ/Ϫ) mice show an almost normal phenotype histologically, but have increased resistance towards lipopolysaccharide/galactosamine-mediated The TNF system toxicity and defects in the clearance of intracellular pathogens such as Listeria and Candida, due to impaired macrophage funcIn contrast to the CD95, the biological function of the TNF system is more complex. In addition to its cytotoxicity, TNF tions [102, 103] . Apart from their deficiency in effector functions, TNF (Ϫ/Ϫ) mice have some defects in lymphoid organogenexerts a number of other activities related to proinflammatory processes on almost all cell types (reviewed in [31Ϫ34]). The esis, in particular in the structural organization of B cell follicles [104] . In contrast to TNF-R1 (Ϫ/Ϫ) mice [105] , deletion of TNFfunction of TNF is also complicated by the the presence of two different TNF receptors, TNF-R1 and TNF-R2, which can be R2 has no apparent influence on lymphoid organ development.
TNF-R2 is critically involved in mediating pathogenicity during occupied by two different ligands. TNF and the LTA homotrimer bind to the TNF receptors, while LTA/LTβ complexes selectively cerebral malaria, in lipopolysaccharide-induced leukostasis and down-regulation of TNF-R1-dependent neutrophil influx in a ligate the LTβ receptor.
TNF was originally found as a factor in endotoxin-primed lung inflammation model [106] . A dominant role of TNF-R1 in mediating pathogenic activities was evident early on from modmice which caused hemorrhagic necrosis of transplanted tumors [95] . It was also identified as a catabolic substance that sup-els of septic shock and arthritis [107, 108] . The growing knowledge about the pathophysiological role of TNF has elicited sevpressed the expression of lipoprotein lipase and other anabolizing enzymes and was therefore termed cachectin [96] . A major eral clinical trials in order to intervene with the deleterious effects of TNF in acute and chronic diseases. cellular source of TNF are activated macrophages, but also lymphoid cells, NK cells, neutrophils, keratinocytes, fibroblasts and smooth muscle cells produce the cytokine in response to various
The TRAMP and TRAIL systems. The biological functions of the new death receptors are largely unknown yet. challenges (reviewed in [31Ϫ34]). Though the first interest in TNF arose from its antitumor activity, it soon became clear that TRAMP (TNF receptor-related apoptosis-mediating protein, DR3) is abundantly expressed in thymocytes and lymphocytes TNF has a wide range of other biological effects and is a mediator of endotoxic shock. An important cellular target of TNF is and may play a role in lymphocyte development [2, 8] . The chromosomal localization of the TRAMP gene has been asthe endothelium where it induces the release of platelet-activating factor, the secretion of various cytokines and the expression signed to the long arm of chromosome 11 where other related receptors (CD30R, TNFR2, OX40R) have been mapped. of adhesion molecules. These responses, together with the activation of arachidonic acid metabolism, commonly result in TRAMP is both structurally and functionally related to the TNF receptors because its overexpression leads to NF-κB activation increased vascular permeability, anticoagulant activity and leukocyte adhesion. Because TNF receptors are ubiquitously ex-and apoptosis. However, the putative ligand for TRAMP still remains to be identified. pressed with the exception of erythrocytes, it is not suprising that almost all cell types respond to TNF. In neutrophils, TNF
The recent cloning of TRAIL and its four receptors revealed a new apoptosis system with apparently high complexity. Also activates respiratory burst and degranulation leading to the release of radicals, proteases and other granular enzymes. Macro-TRAIL can induce both apoptosis and NF-κB activation. In contrast to the restricted expression of CD95L, TRAIL is more phages respond to TNF with enhanced cytotoxic activity and cytokine synthesis. In hepatocytes TNF is, together with IL-1 abundantly expressed in several tissues. Two of the TRAIL receptors, TRAIL-R1 and TRAIL-R2, induce apoptosis in various and IL-6, a mediator of the synthesis of acute-phase proteins. In addition, a multitude of other effects have been described for cancer cells, whereas the decoy receptors DcR1 and DcR2, which are apparently mainly expressed on normal cells, do not several cell types (reviewed in [31Ϫ34]). Many of the proinflammatory activities of TNF are regulated by the transcription contain a functional death domain and confer resistance against TRAIL action [12Ϫ22]. Whether TRAIL might be used to kill factor NF-κB.
Most of the biological activities of TNF including pro-more selectively tumor cells, awaits further experiments. At the moment, it is unclear why there are two death-signaling TRAIL grammed cell death, antiviral activity, and activation of transcription factor NF-κB, are mediated by TNF-R1, while an in-receptors. It is possible that either the two receptors are redundant or provide additional means to regulate apoptosis. Only volvement of TNF-R2 has been demonstrated particularly in Tlymphocytes [97Ϫ100]. Membrane-bound TNF (mTNF) and limited information exists on target cells of TRAIL-induced apoptosis. It was reported that TRAIL can trigger activationsoluble TNF (sTNF) have different affinities to the two recep-induced death of T-cells [10, 109] which may also contribute to complexes have also been identified in vivo using classical biochemical methods [120] . Treatment of cells with agonistic anti-T-lymphocyte death during HIV infection [110, 111] .
APO-1 antibodies and subsequent co-immunoprecipitation of CD95 resulted in the identification of four cytotoxicity-depenDeath receptor-associating proteins dent APO-1-associated proteins (CAP1Ϫ4) on two-dimensional gels, within seconds after receptor triggering. Together with the A major progress in the understanding of death receptor signaling was the definition of the so-called death domain (DD), receptor, these proteins formed the death-inducing signaling complex (DISC). Two spots were identified as two different seran intracellular region of about 80 amino acids that is essential for triggering cell death. Its importance is demonstrated by ine-phosphorylated species of FADD, and it was demonstrated that FADD bound to CD95 in a stimulation-dependent fashion. lpr cg mice which carry a point mutation in the DD of CD95. Delineation of the DD was not only a major aid for the identifiSequencing of the other immunoprecipitated proteins resulted in the identification of a downstream molecule which concation of new death receptors in database searches but also allowed for the identification of new adaptor molecules when used tained two DEDs at its N-terminus that associate with the DED of FADD [121] . At its C-terminus it had the typical domain as a bait in interactive cloning approaches. The DD exerts its effects via interactive properties, as it can self-associate and bind structure of a protease like interleukin-1β converting enzyme (ICE) and was therefore termed FLICE (FADD-like ICE). to the DD of other proteins. These associations between DDs occur as a consequence of receptor-ligand binding and seem to FLICE was also cloned by two other groups and named MACH and Mch5 [122, 123] . It belongs to cysteine proteases of the involve electrostatic interactions. As assessed by NMR spectroscopy, the DD of CD95 comprises a series of antiparallel amphi-caspase family and is therefore now referred to as caspase-8 [124] . Identification of caspase-8 as part of the DISC connected pathic A-helices with many exposed charged residues [112] , although it should be noted that this structure was determined at two different levels in apoptosis pathways, the receptor with the executioner caspases. After receptor engagement, FADD and acidic pH. The tendency of the DD to self-associate apparently strengthens the interactions of the receptors imposed by ligand caspase-8 are recruited to CD95 within seconds. Binding of caspase-8 to FADD presumably causes a structural change, resultbinding. Following self-association, the DD of the receptors recruits other DD-containing proteins which then serve as adaptors ing in autoproteolytic activation of the protease. The active subunits p10 and p18 are released into the cytoplasm, whereas part in the signaling cascades (Fig. 2) .
The first DD-containing adaptor proteins identified were of the prodomain remains bound to the DISC. Presently, it is assumed that active caspase-8 subunits cleave various death sub-FADD (MORT1) [113, 114] , RIP [115] and TRADD [116] . TRADD is most effectively bound following ligation of TNF-strates and other caspases leading to the execution of apoptosis.
Overexpression of functionally inactive FADD and caspase-8 R1, where it then probably serves to recruit the DD proteins FADD and RIP as well as the RING domain adaptor protein did not only block CD95, but also inhibited TNF-R1-induced signaling [122, 125] . This suggested that both receptors are cou-TRAF2. FADD, in contrast, is preferentially recruited to CD95. Thus, the DD of FADD can bind to the DD of TRADD and the pled to a similar signaling complex. However, FADD does not directly bind to TNF-R1 but becomes associated upon binding DD of RIP to the DDs of both TRADD and FADD. These mutual interactions may account for a potential crosstalk of the of the DD-containing protein TRADD. Similarly to TNF-R1, TRAMP can induce apoptosis and activate NF-κB [2, 8, 9, 11]. different receptor signaling pathways.
Overexpression of most DD proteins causes cell death, indi-TRAMP has been reported to bind TRADD, TRAF2, FADD and caspase-8 [8] . Due to its TNF-R1-like structure it is expected to cating that these molecules are involved in apoptosis signaling. In the case of FADD, transient expression of the N-terminal re-have a signaling function analogous to TNF-R1. However, the TRAMP ligand has not been cloned, nor have agonistic antibodgion was sufficient to cause apoptosis [113] . This part of FADD was therefore termed the death effector domain (DED). In con-ies been generated. All information regarding TRAMP is based on overexpression systems. trast, overexpression of the C-terminal DD-containing part, lacking the DED (FADD-DN), protected cells from CD95-mediated TRAIL binds to two apoptosis signaling receptors, TRAIL-R1 and TRAIL-R2. As with the other death receptors, TRAIL apoptosis and functioned as a dominant-negative mutant. This suggested that the N-terminus of FADD is coupled to the cyto-induced-apoptosis involves caspases, because caspase inhibitors as well as overexpression of CrmA and p35 abrogates cell death toxic machinery. Both TRADD and RIP induce apoptosis but can also activate NF-κB, which is a typical feature of TNF- [12, 14, 17, 18, 111, 126] . In fact, it was recently found that TRAIL can activate caspase-8. However, in contrast to CD95 induced signaling [116Ϫ118] . Similar to FADD, the C-terminus of TRADD contains a DD enabling self-association and associa-which strongly activates caspase-8, TRAIL more preferentially activates caspase-10 (FLICE-2), which has a structure similar to tion with the DD of other signaling molecules including TNF-R1 and FADD. TRADD, however, lacks the typical DED present caspase-8 [12] . A number of reports indicate that the proximal signaling pathway of the TRAIL receptors is similar but distinct in FADD.
RIP (receptor-interacting protein) contains an N-terminal ki-from CD95. For instance, Ag8 myeloma cells are sensitive to TRAIL-induced, but not CD95L-mediated apoptosis, although nase domain and a C-terminal DD. It was originally identified as a molecule binding to the cytoplasmic domain of CD95 in a CD95 is expressed in these cells [126] . In addition, it was demonstrated that HeLa cells transfected with dominant-negative two-hybrid system [115] . Therefore, RIP was suggested to play a role in CD95 signaling. Later studies however demonstrated FADD became resistant to CD95 but remained sensitive to TRAIL [10] . Whether apoptosis triggered by the two TRAIL that RIP does not directly bind to CD95 or TNF-R1 but is recruited through the TNF-R adaptor protein TRAF2 [119] . RIP receptors is FADD-dependent, remains controversial. It was initially suggested that neither TRAIL-R1 nor TRAIL-R2 signaling was identified to be crucial for TNF-R1-mediated NF-κB activation. In a mutant cell line deficient in RIP, CD95 signaling was require FADD interaction [13, 14, 16] . More detailed reports, however, showed that overexpression of dominant-negative not affected, whereas TNF-R1-mediated NF-κB activation was blocked [118] .
FADD strongly attenuated apoptosis triggered by both TRAIL receptors [15, 17, 18, 127] . Thus, whether FADD is directly or While most of the information regarding death pathways has been obtained from yeast two-hybrid assays or supra-physiologi-indirectly coupled to TRAIL-R2 signaling requires further investigation. cal overexpression in mammalian cells, for CD95 the signaling Another possible route for death receptor signaling was re-about 20 kDa containing the active center, and two small subunits of about 10 kDa. A detailed survey on the biochemistry of cently suggested by the discovery of a new death adaptor protein, called RAIDD or CRADD (Fig. 2) [128, 129] . It was dem-caspases has recently been provided in excellent reviews [132, 133] . The following section briefly summarizes the involvement onstrated that RAIDD can bind to TNF-R1 in vitro or when overexpressed in 293 cells. RAIDD carries the DD at its C-of individual caspases in death-receptor-mediated apoptosis.
First evidence for the involvement of caspases in CD95-meterminus and at its N-terminus it displays similarities with the prodomain of caspase-2. It was therefore suggested that RAIDD diated apoptosis came from pharmacological experiments that employed selective caspase inhibitors. YVAD and DEVD would engage TNF-R1 via RIP and induce caspase-2 activation. However, the contribution of this pathway to TNF and CD95 chloromethylketones or aldehydes that mimic the P1 Asp residue of caspase substrates, strongly suppressed CD95 and TNF-R1-cytotoxicity in vivo is still unknown.
It was further demonstrated that death receptors can directly mediated killing [134Ϫ136] . Also the poxvirus CrmA protein, designated for cytokine response modifier A, which encodes an trigger signaling pathways other than caspases. MADD (mitogen-activated kinase activating death domain protein) was inhibitor of a number of caspases efficiently abrogated CD95-mediated apoptosis following overexpression in a variety of cell cloned as DD-containing protein that binds to TNF-R1 and activates the MAP kinase ERK2 in a non-apoptotic pathway [130] . types [134Ϫ137] . Enzymatic measurements revealed that CD95 For CD95, a protein called Daxx was identified that specifically readily induced caspase proteolytic activity within minutes after associates with the DD of CD95 [131] . Overexpression of Daxx receptor ligation [135] . stimulates stress-activated protein kinases of the MAP kinase
The importance of caspases has been first demonstrated by family (JNK/SAPK) and enhances apoptosis (Fig. 2) . Thus, a genetic studies in the nematode Caenorhabditis elegans in which single receptor is able to trigger multiple pathways which, in developmental cell death is regulated by the proapoptotic regulaaddition, can participate in induction of cell death. Despite the tors Ced-3 and Ced-4, and the apoptosis inhibitor Ced-9. Ced-3 key role of the DD, the possibility that proteins associated with has been found to exhibit significant similarity to the mammaother intracellular regions of the receptors contribute to the over-lian protease interleukin-1β-converting enzyme (ICE) that is reall pattern of apoptosis cannot be excluded. As will be described quired for the proteolytic processing of the IL-1β precursor to below, there is some evidence for such proteins, which either the active cytokine [138] . In contrast to C. elegans, so far more utilize other signaling mechanisms or which may modify a death than ten mammalian members of the caspase family have been signal elicited at the DD.
identified (reviewed in [132, 133] Mch4/FLICE2 (caspase-10). The third subfamily consists of be activated by proteolytic cleavage. The active enzyme is composed of a heterotetrameric complex of two large subunits of only Nedd2/ICH-1 (caspase-2).
Based
posed to trigger DNA-damage-induced apoptosis by depleting naling is transmitted by sequential caspase activation. However, the exact cascade of caspase activation during execution of the NAD stores. On the other hand, due to its DNA repair activity, PARP may exert a protective function. It has been proposed that, death pathways is still obscure. A direct link between death receptor triggering and caspase activation was established by clon-during CD95-induced apoptosis, cleavage of PARP inhibits most of its DNA repair activity, and thus may contribute to the demise ing of caspase-8 as part of the CD95 DISC [121] . The proform of caspase-8 is recruited to the multimerized receptor and then of the cell [151] . To analyze whether PARP cleavage is critical for cell death, we have recently investigated CD95 and TNFlikely activated by autoproteolytic cleavage [139] . Thus, caspase-8 is the most upstream caspase in the CD95 pathway. As R1-mediated apoptosis in PARP (Ϫ/Ϫ) mice. In a variety of tissues, no difference in apoptosis sensitivity of PARP (Ϫ/Ϫ) and parental discussed previously, either caspase-8 itself or a caspase-8-like protease, such as caspase-10, is involved in a similar fashion in mice was detected [152] . Therefore, although PARP (Ϫ/Ϫ) mice have defects in genomic stability, cleavage of PARP is dispensthe signal transduction of the other death receptors. It is assumed that an apical initiator caspase cleaves and activates downstream able for death receptor signal transduction.
An interesting substrate of caspases is the upstream p21-actiexecutioner caspases, though it is unknown how many caspases are needed for the final demise of the cell. Caspase-8 has been vated kinase-2, PAK2, which is cleaved during CD95-and TNFmediated apoptosis to generate a constitutively active kinase shown to directly cleave caspase-3, -4, -7, -9 and -10 in vitro, while caspase-2 and -6 were cleaved indirectly by other caspase- [153] . Since PAK2 activates the stress-activated protein kinase (SAPK) pathway, it may provide the link between caspases and 8-activated caspases present in cellular extracts [140] . The order of other caspases in this cascade is not clear so far. Caspase-6 JNK/SAPK activation. Interestingly, blocking PAK2 by a dominant-negative mutant prevents the formation of apoptotic bodies has been placed upstream of caspase-3 and -7 [141], but it has also been demonstrated that caspase-3 can cleave and activate during CD95-mediated apoptosis, whereas nuclear apoptosis as well as phosphatidylserine externalization remain unaffected caspase-6, -7 and -9 [123, 142, 143] . A recent study further suggested a branched protease cascade in which caspase-8 activates [153] . This illustrates how different features of apoptosis might be separated at the level of caspase targets. caspase-3 and -7, and caspase-3, in turn, activates caspase-6 [144] .
A direct link between caspases and DNA fragmentation was recently found by the cloning of a hitherto unknown murine The reason for such a great variability of mammalian caspases, in comparison to C. elegans, is unclear. There is no report endonuclease, designated CAD for caspase-activated DNase [154] . CAD is sequestered in the cytosol as a latent form by demonstrating that a single caspase is crucial for apoptosis signaling by death receptors. The most intensively studied caspase binding to the inhibitory subunit ICAD. Upon induction of apoptosis, ICAD is cleaved by caspase-3, which allows the member is caspase-3, which is activated by multiple apoptotic signals. Depletion of caspase-3 by homologous recombination DNase to translocate to the nucleus and to degrade DNA. The structure of ICAD is similar to human DNA fragmenting factor results in excessive accumulation of neuronal cells, due to a lack of apoptosis in the brain, whereas it has no effect in other tis-(DFF) which has previously been reported to be cleaved by caspase-3 and to permit endonuclease activation [155] . It is interestsues. This indicates that caspase-3 may be redundant in many cell types [145] . The role of caspase-1 in apoptosis is also con-ing to note that overexpression of ICAD/DFF blocks chromatin changes of apoptosis, but does not abrogate other morphological troversial. It has been suggested that caspase-1 is involved in CD95-mediated apoptosis of thymocytes, in apoptosis of mam-alterations.
Despite compelling evidence for a key role of FADD-medimary cells following matrix loss, and in lymphocyte apoptosis dependent on DNA damage-induced interferon regulatory ated recruitment of caspase-8 to CD95 and TNF-R1, it should be stressed that the precise scenario of receptor-mediated caspase factor-1 (IRF-1) [146Ϫ148]. However, others could not find an impairment of apoptosis in caspase-1 (Ϫ/Ϫ) mice [149, 150] . activation is still fragmentary and most experiments have only been performed in a limited number of cell lines. Besides the Therefore, either caspase-1 does not play a role in death receptor signaling, or another caspase-1-like protease substitutes for its FADD/caspase-8 pathway, a novel pathway has been identified which is controlled by Apaf-1 (apoptotic protease-activating function in different contexts.
An increasing number of proteins have been found to be factor-1), the mammalian homologue of the C. elegans death regulator Ced-4 [156] (Fig. 3) . It is still unclear whether the cleaved by caspases, and for some of them an apoptotic function could be attributed (reviewed in [132, 133] ). Sometimes cleav-Apaf-1/Ced-4 pathway functions completely independently or is interconnected with the caspase-8 pathway. In C. elegans, Ced-4 age results in the activation of a protein or enzyme, sometimes in its inactivation. Substrates include proteins involved in genome physically interacts with both the Bcl-2 homologue Ced-9 and the caspase Ced-3, thus linking the upstream inhibitor and the function, such as the DNA repair enzyme poly(ADP-ribose) polymerase (PARP), DNA-polymerase kinase, 70-kDa U1, het-downstream effector to a multicomponent death complex [157, 158] . In addition, direct binding between Ced-4 and mammalian eronuclear ribonucleoproteins C, and the 140-kDa component of the DNA replication complex. Regulators of the cell-cycle caspase-1 and caspase-8 has been observed. Human Apaf-1 possesses three distinct domains suggesting that its regulation is progression which are cleaved are the retinoblastoma protein, the p53 regulator MDM-2, the nuclear mitotic-associated protein more complex than that of worm Ced-4. The C-terminal part of Apaf-1 is composed of putative WD40 repeats, followed by a NuMA and the kinases PKC-δ, PITSLRE and MEKK1. The cleavage of lamins, which is dependent on caspase-6, may be stretch of amino acids similar to Ced-4. The N-terminal region of Apaf-1 shares sequence similarity with the N-terminal domain essential for disassembling the nuclear architecture. Important caspase substrates include structural proteins such as Gas2, gel-of Ced-3 and some other mammalian caspases. This domain serves as a so-called caspase recruitment domain (CARD) by solin, β-catenin, keratin 18 and fodrin. Cleavage of these proteins may be responsible for the complete reorganization of the binding to caspases that have a similar CARD motif at their Nterminus [159] . In particular, caspase-9 is recruited to Apaf-1 cellular morphology during apoptosis.
One of the first death substrates found to be cleaved by cas- [160] . In cells not undergoing apoptosis, the CARD is not exposed and therefore not bound to procaspase-9. However, bindpases, particularly caspase-3 and -7, was PARP. The enzyme Fig. 3 . Two principal pathways of apoptosis signal transduction. One death pathway involves FADD-mediated recruitment of caspase-8 to the CD95 receptor complex. Another pathway, which is triggered by many apoptotic stimuli, is initiated at the mitochondrion. An early, not wellunderstood, step is the release of cytochrome c into the cytosol which then binds to the Ced-4 homologue Apaf-1. This event unmasked the CARD motif in Apaf-1 and allows binding of pro-caspase-9 through homophilic interaction. The mitochondrial pathway but not FADD-mediated caspase-8 activation is inhibited by Bcl-2. Anti-apoptotic members of the Bcl-2 family may interfere with the relocalization of cytochrome c or with the binding of cytochrome c to Apaf-1. Because cytochrome c release is also found following death receptor ligation, both pathways may be interconnected at an unknown level.
ing of ATP and cytochrome c, that is released from mitochondria The sphingomyelin pathway during early cell death [161] , presumably induces a conformaAnother apoptotic pathway implicated in death receptor-metional change and unmasks the CARD in Apaf-1 (Fig. 3) . This diated apoptosis involves the generation of ceramide by the hyevent finally culminates in the recruitment and activation of casdrolysis of the phospholipid sphingomyelin. Ceramide is a secpase-9. Similarly to caspase-9, caspase-1 and caspase-2 also ond messenger produced upon activation of sphingomyelinases contain a CARD region. Thus, it is possible that these initiator (SMases) or via de novo synthesis by ceramide synthetase. Two caspases are recruited to Apaf-1 and may act independently of forms of SMases can be distinguished based on their pH optima. FADD and other adaptor proteins. Since relocalization of cytoNeutral SMase has a pH optimum of 7.4, requires Mg 2ϩ ions chrome c is observed during TNF-R1-and CD95-mediated and is found at the plasma membrane. Acidic SMase has the apoptosis, the Apaf-1-controlled pathway may also be functional highest enzymatic activity at pH 5.0, is activated by diacylglycin these systems. However, the link between death receptors, erol and mainly present in lysosomes. A multitude of non-apoApaf-1 and mitochondrial alterations remains to be established. ptotic and apoptotic stimuli can activate sphingomyelin turnover There are some hints that other classes of proteases are also including ionizing irradiation, oxidative stress, treatment with important and contribute to the execution of cell death. In a doxorubicin or ligation of TNF-R1 and CD95 [170Ϫ174]. cloning approach to isolate positive regulators of apoptosis, caCeramide generated as a result of sphingomyelin turnover, in thepsin D, a lysosomal cysteine protease, was found to play a turn, can stimulate various target molecules, such as ceramiderole in cell death mediated by IFNγ, TNF and CD95 [162] . In activated protein kinase (CAP kinase), ceramide-activated proHeLa cells, cell death was inhibited following overexpression of tein phosphatase (identical to PP2A), the protein kinase C isoan antisense cathepsin D construct or inactivation of the protease form ζ, and Raf-1. A specific role for ceramide in mediating with the inhibitor pepstatin A. Furthermore, in TNF cytotoxicity apoptotic signals was suggested by the apoptotic effect of exogein particular serine proteases have been implicated [163, 164] . It nous short-chain ceramides or the treatment of cells with bactewas demonstrated that overexpression of plasminogen activator rial SMase. inhibitor-2 (PAI-2) prevented apoptosis in HT-180 and HeLa TNF-R1 has been shown to activate neutral SMase through cells [165, 166] . In U937 cells, a 24-kDa elastase-like serine FAN (factor-associated neutral SMase), a protein that interacts protease, called AP24, has been purified that is rapidly activated with a stretch of nine amino acids upstream of the DD. A domiduring TNF-induced apoptosis [167, 168] . There are some inhibnant-negative mutant of FAN is able to block TNF-R1-mediated itors of AP24 activation that do not affect caspase-3 but fully neutral SMase activation completely without affecting cell death prevent DNA fragmentation and apoptosis. Interestingly, in [175] . Similarly to TNF-R1, mutant CD95, which is defective TNF-sensitive L929 cells overexpressing CD95, certain inhibiin death signaling, is still able to activate neutral-SMase [172]. tors of serine proteases abolish TNF-mediated but not CD95-Therefore, neutral SMase-mediated ceramide production is premediated cell death [169]. As will be described below, these sumably independent of cell death signaling by CD95 and observations indicate that, in some cell types, distinct effector molecules may participate in both receptor pathways.
TNF-R1.
Ceramide production by acidic SMase is mediated through suggesting that the cytotoxic signal of TNF-R1, and the activation of SAPK/JNK and p38, are two signaling pathways sepathe prior activation of the phosphatidylcholine-specific phospholipase C (PtdCho-PLC). The region of TNF-R1 which initiates rated at the receptor level. CD95 can activate SAPK/JNK and p38, although TRAF2 is not associated with this receptor [187, the PtdCho-PLC/acidic SMase pathway corresponds to the DD of TNF-R1. The xanthogenate compound D609 inhibits this 188]. SAPK/JNK activation has been located downstream of caspases in the CD95 pathway, since it can be blocked by the pathway and is able to prevent TNF-induced cell death in various cell types [176] . However, it has been found that cells from caspase inhibitors. SEK1, an upstream activator kinase of SAPK/JNK, is able to inhibit SAPK/JNK activation when expatients with Niemann-Pick disease type A, which lack functional acidic SMase, are resistant to ionizing irradiation, but not pressed as a dominant-negative mutant without affecting CD95-mediated apoptosis [189] . This suggests that the pathway of to CD95-or TNF-R1-induced apoptosis [177] . Therefore, although both neutral and acidic SMase have been implicated in SAPK/JNK activation is independent from apoptosis induction.
At present, however, there are also data suggesting that MAP ceramide production and death signaling through CD95 and TNF-R1, neither of them seems to be essential or sufficient for kinases may play either a positive or a negative role in the regulation of apoptosis. A recent study identified a novel upstream apoptosis induction by these receptors.
Another metabolizing pathway for ceramide was proposed activator of the MAP kinase pathway, termed ASK-1 (apoptosis signaling kinase-1) [190] . The enzyme is assumed to contribute by Testi and coworkers [178] . Ceramide can be shuttled to the Golgi complex where it is converted to gangliosides. It was to TNF-mediated cytotoxicity, because a kinase-dead ASK-1 mutant inhibited TNF-induced apoptosis. Some studies further found that CD95 ligation or treatment with ceramide resulted in the accumulation of the ganglioside GD3, an event, which was revealed that certain upstream elements of the different MAP kinase cascades are targeted and cleaved by caspases. As meninhibited by caspase inhibitors. Antisense oligonucleotides to GD3 synthetase, which is localized in the Golgi complex, atten-tioned above, PAK2 which is regulated by p21-GTPases, is cleaved during CD95 and TNF-mediated apoptosis, leading to uated apoptosis, whereas overexpression of wild-type enzyme was associated with massive cell death. It was suggested that, a constitutively active kinase. Overexpression of the active Cterminal part of PAK2, which is generated during caspase action, during CD95-mediated apoptosis, GD3 ganglioside may be targeted to mitochondria where it alters mitochondrial function induces apoptosis. Interestingly, a dominant-negative PAK2 inhibited the formation of apoptotic bodies, whereas other signs and causes cell death.
It should be stressed that there is currently much confusion of apoptosis remained unaffected [153] . In addition, MAP kinase kinase-6b (MKK6b), an upstream mediator of p38 and SAPK/ about the role of endogenous ceramide in apoptosis. Whereas some publications place ceramide production upstream of cas-JNK activation, is activated in a caspase-dependent manner and is apparently necessary for CD95-mediated apoptosis in Jurkat pases [179, 180] , others suggest that it acts downstream of caspases, as it can be blocked by caspase inhibitors [92, 181, 182] . cells [191] . Finally, a direct link between death receptor signaling and activation of the SAPK/JNK pathway was identified Moreover, ceramide production may be not necessarily linked to apoptosis, as it is also observed after Ca 2ϩ ionophore treatment through the cloning of Daxx, a protein that interacts with the DD of CD95 and leads to caspase-independent SAPK/JNK actiwithout being associated with cell death [182] . A possible reason for the discrepancy on the role of ceramides may lie in meth-vation. It was demonstrated that a dominant-negative SEK1 mutant was able to block both SAPK/JNK activation and cell death odological problems. Ceramide production is mostly determined in assays using diacylglycerol kinase. In a recent investigation, in certain cells [131] . In contrast, thymocytes deficient in SEK1 were found to be more sensitive towards CD95 and anti-CD3-no ceramide production in response to CD95 ligation could be detected using mass spectroscopy, whereas an apparent increase induced apoptosis, whereas apoptosis induced by other environmental stresses was unaffected [192] . Therefore, a secondary of ceramide was measured by the classical diacylglycerol kinase assay [183] . It was suggested that lysates from apoptotic cells apoptotic pathway may exist in certain cells which is dependent on activation of MAP kinases and may either cooperate with or may stimulate diacylglycerol kinase activity directly, which then falsely reflects increased ceramide production. Thus, whether antagonize the caspase cascade. Clearly, delineation of its biological relevance requires further investigation. sphingomyelin hydrolysis is functionally involved in the propagation of death signals or represents a secondary modulatory pathway has to await careful reexamination.
Reactive oxygen intermediates
Cells die by one of the two mechanisms, necrosis or Stress-activated protein kinases apoptosis. While triggering of a death receptor will lead to apoptosis in most cells, there are some conditions where death There is evidence linking apoptosis induced by CD95 and TNF-R1 to the activation of two MAP kinase homologs, called receptors clearly trigger necrotic cell death. Necrosis is often referred to as accidental cell death and is induced when the the stress-activated protein kinases (SAPKs), also known as c-Jun N-terminal kinase (JNK), and the kinase p38. CD95 and plasma membrane of a cell is irreversibly damaged. Biochemically, these alterations seem to be less regulated than apoptosis, TNF-R1 are able to increase the activity of these kinases although, compared to most stress stimuli activation, CD95-in-and a number of pathways have been implicated in necrosis, including generation of reactive oxygen intermediates, activation duced activation is rather slow but sustained. It is still unclear whether kinase activation contributes to apoptosis or constitutes of phospholipases, perturbation of calcium homeostasis, and unspecific DNA and protein damage (reviewed in [193, 194] ). an independent pathway of death receptor signaling.
When the relationship between SAPK/JNK and apoptosis in In both necrosis and apoptosis, mitochondria obviously play a critical role, as in both forms of cell death a rapid and dramatic response to TNF-R1 ligation was analyzed, it was found that the adaptor protein TRAF2 was involved in SAPK/JNK activation decrease in the mitochondrial membrane potential (∆Ψ m) is observed [195, 196] . The drop in ∆Ψ m is due to permeability tranbut not in apoptosis. Furthermore, a dominant-negative FADD inhibited apoptosis but not kinase activation [184, 185] . Thus, sition and allows molecules to be released from the mitochondrial matrix. In cells treated with apoptogenic agents, antidominant-negative TRAF2 and FADD mutants clearly dissociate SAPK/JNK activation from induction of apoptosis. In addition, apoptotic members of the Bcl-2 family that are localized at the outer mitochondrial membrane prevent permeability transition activation of p38 by TNF is not involved in cell death [186] , and the release of cytochrome c. During necrotic cell death, triggers death very rapidly, while in most cell lines TNF-R1-mediated cell death proceeds more slowly. The reasons for the membrane permeability transition may lead to increased radical production, which in turn will cause cell damage through the different kinetics are unknown, but they are inconsistent with the idea of similar death-inducing complexes of the two receptors. It oxidation of lipids, proteins and other components. This common occurrence of mitochondrial alterations, such as permeabil-has been further observed that a number of cell lines are only sensitive to either CD95 or TNF-R1, although both receptors are ity transition, in necrosis and apoptosis indicates that some signaling processes might be shared between the two forms of cell expressed in similar amounts [205, 206] . death. Although it is not entirely clear which event decides whether a cell undergoes apoptosis or necrosis, the supply with ATP and other energy equivalents are likely determinants of this Cellular anti-apoptotic mechanisms process [197] .
Whether triggering of a death pathway results in apoptosis Among the death ligands, TNF at least has been reported to depends, not only on the expression level of a death effector be able to induce apoptosis and necrosis [198] . A necrotic cell molecules, but also on resistance mechanisms that counteract an death is exemplified, for instance, by TNF-treated L929 fibroapoptogenic signal. Apoptosis is often enhanced by inhibitors of blasts, which are often used as the prototype of TNF-sensitive protein synthesis, indicating that cells produce short-lived anticells. There is ample evidence that during TNF-induced necrosis apoptotic proteins. Since apoptosis serves as an important demitochondria-derived ROIs are the critical mediators of cell fense mechanism to combat viral infections, viruses have develdeath. Already early studies showed that TNF treatment caused oped their own or adopted the host's machinery to suppress ultrastructural abnormalities of mitochondria, as they appeared apoptosis. The identification of viral anti-apoptotic genes led in swollen and contained fewer cristae [199, 200] . Furthermore, many cases to the discovery of their cellular homologues that act when cells were treated with certain antioxidants or kept under to prevent cell death. In the following, we will describe various anaerobic conditions TNF cytotoxicity was strongly reduced mechanisms that interfere with cell death at very distinct steps [200] . Pharmacological experiments revealed that the mitoin the signal transduction pathway of death receptors. chondrial respiratory chain was the major source of TNF-induced formation of reactive oxygen intermediates [200, 201] . It was also observed that cell clones, which had been selected for Receptor-associated mechanisms. The most proximal step to suppress a death receptor pathway is the inhibition of ligand the depletion of mitochondrial DNA (mt-DNA) and therefore lacked mitochondrial respiration, were almost completely resis-binding. Members of the death receptor family can sometimes be found as truncated forms of the extracellular domain, which tant to TNF-induced cytotoxicity [201] . Hence, the evidence suggests that reactive oxygen intermediates generated in the are either derived from alternative gene splicing or from proteolytic shedding. It has been proposed that expression of the solumitochondrial electron transport chain play an important role for TNF-induced necrosis.
ble extracellular part of CD95 is elevated and may account for the defective apoptosis in systemic lupus erythematosus (SLE) Interestingly, cells that are devoid of mtDNA and a functional respiratory chain can still undergo apoptosis, for instance [207] , though this finding could not be confirmed by other investigators [208, 209] . An interesting mechanism of neutralizing induced by staurosporine treatment or CD95 ligation [202] . This can be explained by the fact that mtDNA-deficient cells still a death ligand is found in the TRAIL system. The membrane expression of the decoy receptors DcR1 and DcR2, which binds maintain a mitochondrial membrane potential and may release cytochrome c or other factors that can engage the apoptotic ma-TRAIL without signaling for cell death, is held responsible for the resistance of normal cells to TRAIL cytotoxicity [13, 14, 16, chinery. Thus, although in some cells TNF-R1-and CD95-mediated cell death appears to involve similar signaling pathways, 19Ϫ21].
A further downstream level at which apoptosis can be prethere are also examples demonstrating that death induction by the two death receptors must be distinct. Differences between vented is the signaling activity of a death receptor. A negative regulatory role has been suggested for the C-terminus of CD95, TNF-R1 and CD95 signaling can be even evident within the same cell. L929 cells overexpressing CD95 exhibit typical alter-since deletion of its last 15 amino acids increases apoptosis sensitivity [7] . This region of CD95 has been found to interact with ations of apoptosis when stimulated with anti-CD95, such as membrane blebbing, cytoplasmic shrinkage and internucleoso-a protein-tyrosine phosphatase, called Fas-associated phosphatase-1 (FAP-1) [210] . Overexpression of FAP-1 partially inhibits mal DNA fragmentation. In contrast, in the same cells, TNF induces necrosis as evident by changes in the mitochondrial CD95-induced apoptosis. The region that is required for interaction with FAP-1 has been narrowed down to the last three amino ultrastructure and lack of nuclear apoptotic alterations [83, 169] . Differences between the two receptors are also observed with acids, and microinjection of this tripeptide into cells blocked FAP-1 binding and facilitated CD95 signaling [211] . Yet, so far pharmacological inhibitors. While mitochondrial inhibitors or antioxidants almost completely block TNF-R1-mediated cell conclusions on a negative regulatory role of FAP-1 are based mainly on correlations and only the association of FAP-1 with death, they do not affect CD95-mediated cytotoxicity [83, 203] . These different effects may be related to the distinct morphologi-human but not mouse CD95 has been detected [212] . The markedly different expression pattern of FAP-1 and CD95 rather sugcal forms of cell death that are induced upon CD95 and TNF-R1 in certain cell types.
gest that FAP-1 plays no essential role in CD95 signal transduction. There are other differences between TNF-R1 and CD95-mediated signal transduction. As described above, TNF is a potent Recently, it was suggested that signal transduction of TNF-R1 and CD95 may be modulated by a pathway related to ubiquiinducer of the transcription factor NF-κB and pro-inflammatory gene expression, whereas the biological function of CD95 is tination. A novel protein with sequence similarity to ubiquitin, called sentrin, was found to bind to the DD of CD95 and TNFlargely restricted to apoptosis. As reactive oxygen intermediates have been proposed as second messengers of NF-κB activation R1 [213] . When overexpressed, sentrin provides protection against TNF-and CD95-mediated apoptosis. Sentrin associates (reviewed in [204] ), the lack of NF-κB activation by CD95 may concur with the notion that CD95 signal transduction is indepen-strongly with the ubiquitin-conjugating enzyme UBC9 [214] that was also found to be associated with CD95 [215] . It is believed dent of reactive oxygen intermediates. Another difference is the time course of killing induced by both death receptors. CD95 that UBC9 catalyzes the conjugation of ubiquitin or sentrin to other molecules. Whether this process inhibits cell death by blocking binding of DD adaptor proteins remains to be shown.
FLICE-inhibitory proteins.
Shortly after the discovery of caspase-8 which contains two N-terminal regions related to the DED of FADD, homologous viral proteins were identified that intriguingly lacked caspase activity. These proteins were called v-FLIPs (viral FLICE-inhibitory proteins) because, following overexpression in mammalian cells, they bind to the death-receptor-FADD complex but prevent caspase-8 recruitment [216Ϫ 218]. v-FLIPs are expressed as E8 proteins of several herpes viruses (reviewed in [219] ). For v-FLIP of herpesvirus saimiri-8, it was shown that the protein is expressed in the late lytic cycle and renders cells resistant to CD95 [216] . v-FLIPs consist of two DEDs without a caspase-like catalytic domain. They can thereby act as dominant-negative proteins and compete for cas- Following the identification of viral FLIPs, a cellular homo-IAP members also contain a C-terminal RING finger motif of rather logue, called c-FLIP, was also cloned which presumably acts as unknown function. an important death regulator in mammalian cells [220] . c-FLIP was independently identified by several groups and is also termed Casper, I-FLICE, FLAME-1, CASH, CLARP, and MRIT [221Ϫ226]. Its gene was localized to the long arm of chromo-der spinal muscular atrophy [228] . Subsequently, four other human IAPs, called c-IAP1, c-IAP2, X-IAP and survivin, have some 2 Ze (2q33-34) where the genes for caspase-8 and caspase-10 are also clustered. c-FLIP is expressed in various tissues and been isolated and demonstrated to counteract cell death [105, 229Ϫ231] . c-IAP1 and c-IAP2 were identified as molecules that occurs in two splice variants. Similarly to v-FLIP, the short-form c-FLIP S contains two N-terminal DED motifs through which it are recruited to the cytosolic domain of TNF-R2 via their association with TRAF1 and TRAF2 [105] . c-IAP1, in addition, has can bind to other DED proteins. The long-form FLIP L, in addition, contains a C-terminal region resembling the proteolytic do-been shown to be a component of the TNF-R1 complex via its association with TRAF2 [232] . main in caspase-8 and -10. The most remarkable feature of c-FLIP is that the active-site Cys is absent and substituted by Tyr
The common structural feature of all IAP family members is a Cys/His-rich motif termed the baculovirus IAP repeat (BIR) residue. Therefore c-FLIP can be suggested to be proteolytically inactive.
that is present in one to three copies (Fig. 4) . With the exception of NIAP and survivin, all other IAP family members also conIt was found that c-FLIP can associate with different proteins including FADD, caspase-8 and caspase-3. Also an independent tain a zinc-finger-like RING domain at their carboxy terminus.
The fact that the BIR motif is shared by all members suggest association with the TNF-R1-bound protein TRAF2 and with Bcl-x L has been noted [221, 226] . Curiously, quite opposite ef-a central role for this domain in mediating cellular protection.
Recently, it was shown that some IAP members, including Xfects were reported following transfection of c-FLIP cDNA into mammalian cells. By most groups, a protective effect of c-FLIP IAP, c-IAP1 and c-IAP2, can bind to and potently inhibit certain caspases, such as caspase-3 and -7 [233, 234] . Inhibition of these on TNF-R1, CD95, TRAMP or TRAIL-induced apoptosis was detected [220, 222, 223] . This concurs with observations made caspases was also found in vitro, whereas the activity of the proximal proteases caspase-1, -6 and -8 was not affected. Mutafor the viral homologues that act as dominant-negative inhibitors of caspase-8 activation. In contrast, other studies reported a tional analysis revealed that the BIR domains were sufficient for the inhibitory effect, though proteins that retained the RING finmarked cytotoxic effect of c-FLIP [221, 225, 226] . This proapoptotic effect could result from the ability of c-FLIP to acti-ger domain were more efficient. In contrast to the other human IAPs, NIAP did not bind or inhibit caspases [234] , suggesting vate caspase-8 via homophilic interaction through its corresponding DED, which would be similar to the mechansism sug-that IAPs may have additional targets of apoptosis inhibition. A detailed analysis of the mechanism of inhibition revealed that gested for FADD/caspase-8 interaction. This discrepancy in the observed effects may also be due to the cell line used or the IAPs bind, but are not cleaved by, the caspases [234] . This is in contrast to the poxvirus inhibitor CrmA and baculovirus protein supraphysiological range of expression in transfection experiments. Because a pro-apoptotic effect of c-FLIP was seen espe-p35 which require peptide bond hydrolysis as part of their inhibitory mechanism [235Ϫ237]. cially following massive overexpression of the protein, the true function of c-FLIP may be the inhibition of apoptosis. This noAt present, the role of c-IAP1/2 recruitment to the TNF receptors is unknown. Inhibition of caspases is independent of tion is consistent with the amount of c-FLIP in T-lymphocytes. c-FLIP is strongly expressed in early activated T-cells where it TNF-R binding function [234] , though it is possible that recruitment of IAPs to the TNF-R may promote their interaction with was shown that caspase-8 is not recruited to the CD95/FADD complex [227] . c-FLIP expression, however, declines later, when caspases. Alternatively, it has been also suggested that the function of c-IAP2 may be associated with the activation of NF-κB, T-cells become susceptible to CD95. which is known to play the role of an anti-apoptotic transcription factor (see below). Overexpression of c-IAP2 directly stimulated The family of IAPs. Inhibitor of apoptosis proteins (IAPs) constitute a family of conserved molecules which were origi-NF-κB activation and interfered with TNF-induced cell death [238] . This effect required the RING domain of c-IAP2 indicatnally discovered in baculovirus. The first human IAP identified was the neuronal apoptosis inhibitory protein (NIAP) which was ing that, in addition to caspase inhibition, IAPs may prevent apoptosis by alternative mechanisms. isolated based on its contribution to the neurodegenerative disor-The Bcl-2 family of proteins. Bcl-2 proteins constitute another important decisional point of cell death. The Bcl-2 family consists of two functional classes of proteins including antiapoptotic members, such as Bcl-2, Bcl-x L , Mcl-1, Bcl-w, Bfl-1, Brag-1 and A1, as well as pro-apoptotic molecules, such as Bax, Bad, Bak, Bid, Bik, Bim and Hrk (reviewed in [239, 240] ). Bcl-2 members are characterized by up to four so-called Bcl-2 homology (BH) domains, and can interact with each other through a complex network of homo-and heterodimers. Originally, it has been proposed that the ratio of pro-and anti-apoptotic members dictates whether a cell responds to a proximal apoptotic stimulus or not. Indeed, overexpression of Bcl-2/Bcl-x L abrogates cell death, while enforced expression of Bax promotes apoptosis [241, 242] . Recent evidence, however, has challenged the model of heterodimerization of Bcl-2 proteins. Selected Bcl-x L mutants which fail to heterodimerize with Bax can still inhibit apoptosis [243, 244] . Vice versa, mutants of Bax and Bak which do not bind Bcl-x L still exert their pro-apoptotic activity [245, 246] . It therefore seems that these Bcl-2 family members instead of heterodimerizing compete for a common binding partner. Bcl-2, the processing of downstream caspases including caswhich can interact with FADD and thereby activate the proximal caspase pase-3 is prevented by Bcl-2 or Bcl-xL in many apoptotic sys-cascade. tems [248, 249] . Thus, Bcl-2 proteins may inhibit cell death by acting downstream of initiator but upstream of executioner caspases.
The principal site of action of Bcl-2 is presumably the miWhereas many data favour the idea of Bcl-2 proteins as intochondrion, as Bcl-2 seems to prevent all alterations of hibitors of cytochrome c relocalization, very recent results cast apoptosis that occur in this organelle (Fig. 3) . Bcl-2-inhibitory doubt on the hypothesis that cytochrome c release may regulate proteins have been shown to prevent the formation of mito-apoptosis in general. MCF-7 cells which are deficient for caschondrial reactive oxygen intermediates, alterations in calcium pase-3 were found to be refractory to microinjected cytochrome homeostasis, and mitochondrial membrane permeability transi-c, although Bcl-x L efficiently prevented CD95 and TNF-R1-metion. Interesting findings also came from cell-free experiments. diated apoptosis [259] . Furthermore, it has been observed that Bcl-2 prevents the release of an apoptogenic protease, called Bcl-2 inhibits Bax-induced caspase activation and apoptosis, but apoptosis-inducing factor, by isolated mitochondria [250] . Ex-not cytochrome c release. Bcl-2 was found to confer protection periments in vitro demonstrated that Bcl-2 proteins can interact even in response to injected cytochrome c [254] . These findings with Apaf-1 and caspase-9 and may thereby sequester this ter-therefore suggest that effects of Bcl-2 may not be solely exnary complex at the outer mitochondrial membrane [251] . Vari-plained by the inhibition of cytochrome c release. It is possible ous studies revealed that Bcl-2 inhibits the release of cyto-that Bcl-2 inhibits apoptosis by binding to cytochrome c or chrome c which otherwise, upon binding to Apaf-1, would acti-Apaf-1, thereby preventing caspase activation. vate the caspase cascade [252, 253] . In addition, cytochrome c It is still very controversial whether Bcl-2 essentially affects could induce apoptotic alterations and caspase cleavage in vitro apoptosis induced by CD95 or other death receptors. There are or when microinjected into cells [254] .
certain cell types where Bcl-2 or related proteins provide potent The mechanisms of cytochrome c release and its inhibition protection against CD95-induced apoptosis [260, 261] , while by Bcl-2 are unknown. An interesting hint may be provided by there are other cells in which Bcl-2 is completely ineffective the three-dimensional structure of Bcl-x L which reveals a simi- [262, 263] . Since CD95-mediated caspase-8 activation at the larity to the pore-forming domains of some bacterial toxins DISC level is not inhibited by Bcl-x L , execution of apoptosis [255] . Indeed, both Bcl-2 and Bcl-x L have been shown to form could be independent of the release of cytochrome c and other ion channels in artificial lipid bilayers [256, 257] . Different pro-apoptotic mitochondrial components. In contrast, Bcl-2 may Bcl-2 family members might form channels with distinct selec-inhibit cell death in such cells, where execution of apoptosis tivity which could regulate permeability of the outer mito-depends on cytochrome c and Apaf-1-induced activation of exechondrial membrane. It has been shown that Bcl-2 inhibits mito-cutioner caspases [264] . It will be interesting to investigate how chondrial swelling during apoptosis that is presumably caused the FADD/caspase-8 pathway is connected to mitochondria and by a damage of the outer mitochondrial membrane [258] . This whether caspase-8 can directly cause mitochondrial swelling, for osmotic swelling precedes redistribution of cytochrome c and instance by cleavage of proteins at the outer mitochondrial membrane. permeability transition.
NF-κB and additional anti-apoptotic mechanisms. Cells providing protection against TNF necrosis which is largely dependent on formation of reactive oxygen intermediates [277] . contain a variety of other mechanisms which can counteract apoptotic or necrotic cell death. Heat-shock proteins (Hsps) con-c-IAP2 is an NF-κB-controlled gene product which, as described above, presumably inhibits apoptosis at the level of either casstitute a group of molecules that are induced by multiple stress stimuli and, following overexpression, confer enhanced survival pases or proximal TNF receptor signal transduction.
Gene expression of A20 is tightly regulated by NF-κB that of cells exposed to apoptosis-inducing agents. Overexpression of Hsp70 protects against TNF-induced apoptosis [265] and, binds at two κB-binding sites within its promoter [278] . Overexpression of A20 can provide protection against cell death by likewise, enforced expression of small Hsps confers resistance against oxidative stress, TNF, CD95, staurosporine and antican-TNF, but not by serum depletion, oxidative stress or CD95 [279, 280] . Though the biochemical mechanism of action of A20 is cer drugs [266] . The molecular mechanism by which Hsps protect against apoptosis is largely undefined. It has been hypothe-unknown, it has been found that A20 interacts with the TNFreceptor-associated proteins TRAF1 and TRAF2 [281] . How sized that small Hsps protect cells by inhibiting the action of reactive oxygen intermediates, because overexpression led to an A20 inhibits apoptosis, which, as mentioned above, is not mediated by TRAF1/TRAF2 but by TRADD, remains to be increased amount of the antioxidant glutathione and decreased lipid peroxidation. Hsps may also counteract disruption of the determined. It is interesting to note that transfection of A20 in RelA (Ϫ/Ϫ) cells does not rescue these cells from TNF-induced microfilament network which often occurs during apoptosis.
Many cell types that are resistant to apoptosis induced by apoptosis [270] , suggesting that additional resistance genes must be involved. The function of NF-κB as a regulatory loop that death receptors become sensitive in the presence of inhibitors of macromolecular synthesis. This observation indicates that trig-provides protection against apoptosis, has presumably important implications for tumor therapy. If tumor cell sensitivity is congering of a death receptor may simultaneously initiate a genetic programme that blocks cell death. There is now ample evidence trolled by NF-κB, a selective inhibition of NF-κB may result in improved efficacy of anticancer therapy. to suggest that transcription factor NF-κB largely controls antiapoptotic gene expression [267] . NF-κB, which was previously known mainly as a mediator of inflammatory gene expression, Conclusions consists of a heterodimeric complex often composed of p50 and the 65-kDa RelA subunit (Fig. 5) . In its inactive state, the comThis review describes the different death receptors and the plex is sequestered in the cytosol by an inhibitory subunit, called pathways that are used either to induce or to counteract IκB. Upon stimulation of cells, IκB is phosphorylated at N-ter-apoptosis. Certainly, the rapid discovery of the great variety of minal Ser residues and proteolytically degraded, which then al-different death receptors with their multitude of control points lows NF-κB to translocate to the nucleus and activate target proceeds well ahead of our understanding of their role in the genes. The signal-induced phosphorylation of IκB has been re-organism. Our present view of the different functions of the varicently shown to involve the TRAF-2-associating kinase NIK ous death systems is still restricted and it can be anticipated (NF-κB-inducing kinase) which subsequently activates the IκB that even more components of their signaling pathways will be kinase (IKK-1/-2) in a multisubunit complex [268] .
identified. A major objective of future research will be to study A first hint for the involvement of NF-κB in protecting the biological function of death systems and to address questions against cell death came from NF-κB RelA-knockout mice which such as why there are different death systems, how they operate died before birth and showed massive apoptotic degeneration of and what ensures their specificity. Another challenge is to apply liver cells [269] . It was further demonstrated that fibroblasts and the knowledge of death receptor networks to therapy. Therapeumacrophages from RelA-deficient mice are hypersensitive to tic targeting of certain death pathways would be beneficial for TNF-induced cytotoxicity, whereas wild-type cells survive this very diverse diseases including AIDS, hepatitis, neurodegeneratreatment [270] . In another approach, it was demonstrated that tion, multiple sclerosis, stroke, myocardial ischemia and others. cells were sensitized to TNF, chemotherapeutic drugs and ioniz-While the goal of treating these diseases is to prevent cell death, ing irradiation, when NF-κB activation was blocked by a domi-the major challenge in treating cancer is to kill cells that are nant-negative IκB mutant [271, 272] . In addition, B-lymphocyte resistant to available chemotherapy. Since the failure to undergo cell lines constitutively express NF-κB, but inactivation of NF-apoptosis is often associated with drug resistance, direct activa-κB by various means induces apoptosis [273] .
tion of physiological death pathways may be an effective strat-A general role for NF-κB as a transcription factor that pre-egy to kill tumor cells. vents cell death is, however, not established. Apoptosis triggered by CD95 is not countered by NF-κB [272] , presumably because tamate-induced toxicity of neurons, as blocking its activation with salicylate protected cells from excitotoxic damage [274] . Apoptosis induced by serum withdrawal was demonstrated to References induce NF-κB activation which was prevented by overexpres- hydrogen peroxide inside mitochondria, may be involved by
